Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
9.48
-7.12 (-42.89%)
At close: Jun 27, 2025, 4:00 PM
9.50
+0.02 (0.19%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $246.62 million as of June 27, 2025. Its market cap has decreased by -29.64% in one year.
Market Cap
246.62M
Enterprise Value
451.76M
1-Year Change
-29.64%
Ranking
Category
Stock Price
$9.48
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $246.62M, a decrease of -28.73%. That is a compound annual growth rate of -7.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 246.62M | 207.89% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.50B |
| Johnson & Johnson | 367.07B |
| AbbVie | 330.30B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 273.63B |
| Abbott Laboratories | 240.72B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |